Xperix Inc. (KOSDAQ:317770)
South Korea · Delayed Price · Currency is KRW 3,650.00
-50.00 (-1.35%)
At close: Aug 7, 2025, 3:30 PM KST
Revance Therapeutics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
Operating Revenue | 17,712 | 14,747 | 11,909 | 15,078 | 14,518 | 8,382 | Upgrade |
Other Revenue | - | - | - | -0 | -0 | - | Upgrade |
| 17,712 | 14,747 | 11,909 | 15,078 | 14,518 | 8,382 | Upgrade | |
Revenue Growth (YoY) | 59.67% | 23.83% | -21.02% | 3.85% | 73.22% | -30.61% | Upgrade |
Cost of Revenue | 9,786 | 8,165 | 6,819 | 6,891 | 7,194 | 4,738 | Upgrade |
Gross Profit | 7,926 | 6,582 | 5,090 | 8,187 | 7,324 | 3,644 | Upgrade |
Selling, General & Admin | 9,122 | 7,691 | 6,790 | 3,767 | 2,975 | 2,540 | Upgrade |
Research & Development | 1,268 | 1,445 | 2,000 | 1,292 | 1,111 | 1,180 | Upgrade |
Other Operating Expenses | 41.95 | 34.82 | 69.8 | 52.3 | 47.53 | 48.43 | Upgrade |
Operating Expenses | 12,568 | 11,330 | 9,274 | 5,369 | 4,323 | 3,778 | Upgrade |
Operating Income | -4,641 | -4,748 | -4,184 | 2,818 | 3,001 | -134.13 | Upgrade |
Interest Expense | -5,974 | -4,733 | -18.61 | -9.28 | -11.64 | -14.43 | Upgrade |
Interest & Investment Income | 668.26 | 875.1 | 1,066 | 456.87 | 302.46 | 414.26 | Upgrade |
Earnings From Equity Investments | -2,134 | -1,811 | -400.68 | -246.25 | -138.73 | 48.18 | Upgrade |
Currency Exchange Gain (Loss) | 147.93 | 457.52 | 190.27 | -8.1 | 278.21 | -239.16 | Upgrade |
Other Non Operating Income (Expenses) | 1,765 | 2,375 | -54.96 | -30.59 | -27.35 | -11.24 | Upgrade |
EBT Excluding Unusual Items | -10,168 | -7,584 | -3,402 | 2,980 | 3,404 | 63.48 | Upgrade |
Gain (Loss) on Sale of Investments | 8,590 | 7,527 | -726.99 | 70.96 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -3.51 | -3.36 | 0.06 | - | -0.23 | 0.17 | Upgrade |
Asset Writedown | -509.98 | -509.98 | -1,365 | -65.43 | -38.49 | -13.35 | Upgrade |
Pretax Income | -2,091 | -570.04 | -5,494 | 2,986 | 3,366 | 50.29 | Upgrade |
Income Tax Expense | 3,211 | 2,794 | -1,780 | -111.3 | 111.13 | -676.56 | Upgrade |
Earnings From Continuing Operations | -5,302 | -3,364 | -3,714 | 3,097 | 3,255 | 726.86 | Upgrade |
Minority Interest in Earnings | 441.65 | 344.98 | 69.64 | -69.09 | -30.69 | 60.41 | Upgrade |
Net Income | -4,861 | -3,019 | -3,644 | 3,028 | 3,224 | 787.26 | Upgrade |
Net Income to Common | -4,861 | -3,019 | -3,644 | 3,028 | 3,224 | 787.26 | Upgrade |
Net Income Growth | - | - | - | -6.08% | 309.50% | -24.20% | Upgrade |
Shares Outstanding (Basic) | 24 | 23 | 22 | 21 | 21 | 21 | Upgrade |
Shares Outstanding (Diluted) | 24 | 23 | 22 | 21 | 21 | 21 | Upgrade |
Shares Change (YoY) | 8.44% | 5.53% | 1.84% | 0.27% | 0.49% | 13.81% | Upgrade |
EPS (Basic) | -206.56 | -131.41 | -167.38 | 141.64 | 151.21 | 37.29 | Upgrade |
EPS (Diluted) | -206.56 | -131.41 | -167.38 | 141.64 | 151.14 | 37.14 | Upgrade |
EPS Growth | - | - | - | -6.29% | 306.92% | -33.33% | Upgrade |
Free Cash Flow | -4,636 | -3,693 | -925.38 | 2,500 | 1,820 | 3,083 | Upgrade |
Free Cash Flow Per Share | -196.99 | -160.75 | -42.51 | 116.94 | 85.36 | 145.31 | Upgrade |
Gross Margin | 44.75% | 44.63% | 42.74% | 54.30% | 50.45% | 43.47% | Upgrade |
Operating Margin | -26.21% | -32.20% | -35.13% | 18.69% | 20.67% | -1.60% | Upgrade |
Profit Margin | -27.44% | -20.47% | -30.60% | 20.08% | 22.21% | 9.39% | Upgrade |
Free Cash Flow Margin | -26.17% | -25.04% | -7.77% | 16.58% | 12.54% | 36.78% | Upgrade |
EBITDA | -3,743 | -3,807 | -3,377 | 3,342 | 3,487 | 427.44 | Upgrade |
EBITDA Margin | -21.13% | -25.81% | -28.36% | 22.16% | 24.02% | 5.10% | Upgrade |
D&A For EBITDA | 898.46 | 940.76 | 806.31 | 524.06 | 485.24 | 561.57 | Upgrade |
EBIT | -4,641 | -4,748 | -4,184 | 2,818 | 3,001 | -134.13 | Upgrade |
EBIT Margin | -26.21% | -32.20% | -35.13% | 18.69% | 20.67% | -1.60% | Upgrade |
Effective Tax Rate | - | - | - | - | 3.30% | - | Upgrade |
Advertising Expenses | - | 314 | 221.79 | 179.33 | 75.61 | 35.67 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.